Strategic Growth Danforth Health has a broad life sciences focus with capabilities across strategy, regulatory, clinical operations, and commercialization, presenting opportunities to partner with mid to large biotechs seeking end-to-end support to accelerate discovery through launch.

Market Access Expansion Recent hires and acquisitions expand Market Access and payer engagement capabilities, signaling a growing demand area where life science clients may need advisory services to optimize reimbursement, pricing strategy, and stakeholder advocacy.

Recent Partnerships Partnership with Protagenic Therapeutics as a regulatory strategic and strategic operations advisor highlights opportunities to engage with companies pursuing regulatory strategy and operational readiness for rapid programs and portfolio diversification.

Acquisition Momentum Acquiring Asymmetry Group strengthens go-to-market execution and patient impact initiatives, suggesting cross-sell opportunities to clients seeking enhanced commercialization, market access, and real-world evidence capabilities.

Scale Ready With 201-500 employees and revenue in the hundred millions, Danforth Health is positioned to serve growing life sciences companies that require flexible, scalable operations support, creating upsell potential for expanded program management, regulatory operations, and clinical operations services.